secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2021-12-13T23:59:59+00:00
Accession:  0001193805-21-001738
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02, 5.05, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus appoints Dr. Jing Marantz to board of directors effective Dec. 7, 2021
-------------------------------------------------------------------------------

- Dr. Marantz, SVP Head of Medical Affairs at Acceleron (Merck subsidiary), joins Arcturus board with immediate effect.
- She brings experience from Alnylam, Alexion, Biogen; led global product launches for ONPATTRO and GIVLAARI.
- Board also adopted new Code of Business Conduct and Ethics replacing prior code effective Dec. 7, 2021.
- No other material changes; no financial impact disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380521001738/0001193805-21-001738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380521001738/e621155_8k-at.htm
  HTML page:      https://secwatch.observer/filing/0001193805-21-001738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer